Resveratrol modulates tumor cell proliferation and protein translation via SIRT1 -dependent AMPK activation

Journal of Agricultural and Food Chemistry

Volumn 58, Issue 3, 2010, Pages 1584-1592

  Lin, Jia Ni ^a   Lin, Victor Chia Hsiang ^b   Rau, Kun Ming ^c   Shieh, Po Chuen ^d   Kuo, Daih Huang ^d   Shieh, Jia Ching ^e   Chen, Wei Jen ^e   Tsai, Shih Chang ^a   Way, Tzong Der ^a  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b I SHOU UNIVERSITY   (Taiwan)

^c CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^d TAJEN UNIVERSITY   (Taiwan)

^e CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

Author keywords

AMPK; Caloric restriction; LKB1; Resveratrol; SIRT1

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; RESVERATROL; SIRT1 PROTEIN, HUMAN; SIRTUIN 1; STILBENE DERIVATIVE;

ANIMAL; ARTICLE; BAGG ALBINO MOUSE; CELL PROLIFERATION; DRUG EFFECT; ENZYME ACTIVATION; FEMALE; GENE EXPRESSION; GENETICS; HUMAN; METABOLISM; MOUSE; NEOPLASM; NUDE MOUSE; PATHOPHYSIOLOGY; PROTEIN SYNTHESIS; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

AMP-ACTIVATED PROTEIN KINASES; ANIMALS; CELL LINE, TUMOR; CELL PROLIFERATION; ENZYME ACTIVATION; FEMALE; GENE EXPRESSION; HUMANS; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASMS; PROTEIN BIOSYNTHESIS; SIGNAL TRANSDUCTION; SIRTUIN 1; STILBENES;

MAMMALIA;

EID: 76449110705     PISSN: 00218561     EISSN: 15205118     Source Type: Journal    
DOI: 10.1021/jf9035782     Document Type: Article

References (47)

1. Gehm, B. D.; McAndrews, J. M.; Chien, P. Y.; Jameson, J. L. Resveratrol, a polyphenols compound found in frapes and wine, is an agonist for the estrogen receptor. Proc. Natl. Acad. Sci. U.S.A. 1997, 25, 14138-14143.
2. Lu, R.; Serrero, G. Resveratrol, a natural product derived from grape, exhibits antiestrogenic activity and inhibits the growth of human breast cancer cells. J. Cell. Physiol. 1999, 179, 297-304. (Pubitemid 29203154)
3. Jang, M.; Cai, L.; Udeani, G. O.; Slowing, K. V.; Thomas, C. F.; Beecher, C. W.; Fong, H. H.; Farnsworth, N. R.; Kinghorn, A. D.; Mehta, R. G.; Moon, R. C.; Pezzuto, J. M. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 1997, 275, 218-220. (Pubitemid 127696281)
4. Bradamante, S.; Barenghi, L.; Villa, A. Cardiovascular protective effects of resveratrol. Cardiovasc. Drug Rev. 2004, 22,169-188.
5. Lagouge, M.; Argmann, C.; Gerhart-Hines, Z.; Meziane, H.; Lerin, C.; Daussin, F.; Messadeq, N.; Milne, J.; Lambert, P.; Elliott, P.; Geny, B.; Laakso, M.; Puigserver, P.; Auwerx, J. Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-Iα. Cell 2006, 127, 1109-1122. (Pubitemid 44894520)
6. Baur, J. A.; Pearson, K. J.; Price, N. L.; Jamieson, H. A.; Lerin, C.; Kalra, A.; Prabhu, V. V.; Allard, J. S.; Lopez-Lluch, G.; Lewis, K.; Pistell, P. J.; Poosala, S.; Becker, K. G.; Boss, O.; Gwinn, D.; Wang, M.; Ramaswamy, S.; Fishbein, K. W.; Spencer, R. G.; Lakatta, E. G.; Le Couteur, D.; Shaw, R. J.; Navas, P.; Puigserver, P.; Ingram, D. K.; de Cabo, R.; Sinclair, D. A. Resveratrol improves health and survival of mice on a high-calorie diet. Nature 2006, 444, 337-342.
7. Wang, Q.; Xu, J.; Rottinghaus, G. E.; Simonyi, A.; Lubahn, D.; Sun, G. Y.; Sun, A. Y. Resveratrol protects against global cerebral ischemic injury in gerbils. Brain Res. 2002, 955, 439-447.
8. Rogina, B.; Helfand, S. L.; Frankel, S. Longevity regulation by Drosophila Rpd3 deacetylase and caloric restriction. Science 2002, 298, 1745. (Pubitemid 35404109)
9. Koubova, J.; Guarente, L. How does calorie restriction work? Genes 2003, 77, 313-321. (Pubitemid 36182188)
10. Cabelof, D. C.; Yanamadala, S.; Raffoul, J. J.; Guo, Z.; Soofi, A.; Heydari, A. R. Caloric restriction promotes genomic stability by induction of base excision repair and reversal of its age-related decline. DNA Repair 2003, 2, 295-307.
11. Zhang, J. Resveratrol inhibits insulin responses in a SirTl-independent pathway. Biochem. J. 2006, 397, 519-527. (Pubitemid 44187510)
12. Wood, J. G.; Rogina, B.; Lavu, S.; Howitz, K.; Helfand, S. L.; Tatar, M.; Sinclair, D. Sirtuin activators mimic caloric restriction and delay ageing in metazoans. Nature 2004, 430, 686-689. (Pubitemid 39061685)
13. Corton, J. M.; Gillespie, J. G.; Hawley, S. A.; Hardie, D. G. 5aminoimidazole-4-carboxamide ribonucleoside. A specific method for activating AMP-activated protein kinase in intact cells? Eur. J. Biochem. 1995, 229, 558-565.
14. Davies, S. P.; Helps, N. R.; Cohen, P. T.; Hardie, D. G. 5′-AMP inhibits dephosphorylation, as well as promoting phosphorylation, of the AMP-activated protein kinase. Studies using bacterially expressed human protein phosphatase-2C a and native bovine protein phosphatase-2AC. FEBS Lett. 1995, 377, 421-425.
15. Hawley, S. A.; Davison, M.; Woods, A.; Davies, S. P.; Beri, R. K.; Carling, D.; Hardie, D. G. Characterization of the AMP-activated protein kinase kinase from rat liver and identification of threonine 172 as the major site at which it phosphorylates AMP-activated protein kinase. J. Biol. Chem. 1996, 271, 27879-27887.
16. Kemp, B. E.; Mitchelhill, K. L; Stapleton, D.; Michell, B. J.; Chen, Z. P.; Witters, L. A. Dealing with energy demand: the AMP-activated protein kinase. Trends Biochem. Sci. 1999, 24, 22-25. (Pubitemid 29074459)
17. Mothe-Satney, I.; Gautier, N.; Hinault, C.; Lawrence, J. C., Jr.; Van Obberghen, E. In rat hepatocytes glucagon increases mammalian target of rapamycin phosphorylation on serine 2448 but antagonizes the phosphorylation of its downstream targets induced by insulin and amino acids. J. Biol. Chem. 2000, 275, 33836-33843.
18. Gingras, A. C.; Raught, B.; Gygi, S. P.; Niedzwiecka, A.; Miron, M.; Burley, S. K.; Polakiewicz, R. D.; Wyslouch-Cieszynska, A.; Aebersold, R.; Sonenberg, N. Hierarchical phosphorylation of the translation inhibitor 4E-BP1. Genes Dev. 2001, 15, 2852-2864. (Pubitemid 33042055)
19. Wang, X.; Beugnet, A.; Murakami, M.; Yamanaka, S.; Proud, C. G. Distinct signaling events downstream of mTOR cooperate to mediate the effects of amino acids and insulin on initiation factor 4Ebinding proteins. Mol. Cell. Biol. 2005, 25, 2558-2572.
20. Faivre, S.; Kroemer, G.; Raymond, E. Current development of mTOR inhibitors as anticancer agents. Nat. Rev. Drug Discov. 2006, 5, 671-688. (Pubitemid 44151605)
21. Hwang, J. T.; Kwak, D. W.; Lin, S. K.; Kim, H. M.; Kim, Y. M.; Park, O. J. Resveratrol induces apoptosis in chemoresistant cancer cells via modulation of AMPK signaling pathway. Ann. N. Y. Acad. Sci. 2007, 1095, 441-448. (Pubitemid 47092474)
22. Baur, J. A.; Pearson, K. J.; Price, N. L.; Jamieson, H. A.; Lerin, C.; Kalra, A.; Prabhu, V. V.; Allard, J. S.; Lopez-Lluch, G.; Lewis, K.; Pistell, P. J.; Poosala, S.; Becker, K. G.; Boss, O.; Gwinn, D.; Wang, M.; Ramaswamy, S.; Fishbein, K. W.; Spencer, R. G.; Lakatta, E. G.; Le Couteur, D.; Shaw, R. J.; Navas, P.; Puigserver, P.; Ingram, D. K.; de Cabo, R.; Sinclair, D. A. Resveratrol improves health and survival of mice on a high-calorie diet. Nat. Rev. Drug Discov. 2006, 5, 493-506.
23. Wallace, D. C. A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: a dawn for evolutionary medicine. Annu. Rev. Genet. 2005, 39, 359-407.
24. Selman, C.; Kendaiah, S.; Gredilla, R.; Leeuwenburgh, C. Increased hepatic apoptosis during short-term caloric restriction is not associated with an enhancement in caspase levels. Exp. Gerontol. 2003, 38, 897-903. (Pubitemid 36952671)
25. Way, T. D.; Kao, M. C.; Lin, J. K. Apigenin induces apoptosis through proteasomal degradation of HER2/neu in HER2/neu-overexpressing breast cancer cells via the phosphatidylinositol 3-kinase/ Akt-dependent pathway. J. Biol. Chem. 2004, 279, 4479-4489.
26. Dasgupta, B.; Milbrandt, J. Resveratrol stimulates AMP kinase activity in neurons. Proc. Natl. Acad. Sci. U.S.A. 2007, 104, 7217-7222. (Pubitemid 47186035)
27. Yamamoto, H.; Schoonjans, K.; Auwerx, J. Sirtuin functions in health and disease. Mol. Endocrinol. 2007, 21, 1745-1755.
28. Howitz, K. T.; Bitterman, K. J.; Cohen, H. Y.; Lamming, D. W.; Lavu, S.; Wood, J. G.; Zipkin, R. E.; Chung, P.; Kisielewski, A.; Zhang, L. L.; Scherer, B.; Sinclair, D. A. Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature 2003, 425, 191-196.
29. Chen, D.; Guarente, L. SIR2: apotential target for calorie restriction mimetics. Trends Mol. Med. 2007, 13, 64-71.
30. Woods, A.; Dickerson, K.; Heath, R.; Hong, S. P.; Momcilovic, M.; Johnstone, S. R.; Carlson, M.; Carling, D. Ca2+/calmodulin-dependent protein kinase kinase-β acts upstream of AMP-activated protein kinase in mammalian cells. Cell Metab. 2005, 2, 21-33. (Pubitemid 43239822)
31. Shaw, R. J.; Kosmatka, M.; Bardeesy, N.; Hurley, R. L.; Witters, L. A.; DePinho, R. A.; Cantley, L. C. The tumor suppressor LKB1 kinase directly activates AMP-activated kinase and regulates apoptosis in response to energy stress. Proc. Natl. Acad. Sci. U.S.A. 2004, 101, 3329-3335.
32. Hara, K.; Yonezawa, K.; Weng, Q. P.; Kozlowski, M. T.; Belham, C.; Avruch, J. Amino acid sufficiency and mTOR regulate p70 S6 kinase and eIF-4E BPl through a common effector mechanism. J. Biol. Chem. 1998, 273, 14484-14494. (Pubitemid 28319170)
33. Ruggero, D.; Montanaro, L.; Ma, L.; Xu, W.; Londei, P.; CordonCardo, C.; Pandolfi, P. P. The translation factor eIF-4E promotes tumor formation and cooperates with c-Myc in lymphomagenesis. Nat. Med. 2004, 10, 484-486.
34. Wendel, H. G.; De Stanchina, E.; Fridman, J. S.; Malina, A.; Ray, S.; Kogan, S.; Cordon-Cardo, C.; Pelletier, J.; Lowe, S. W. Survival signalling by Akt and eIF4E in oncogenesis and cancer therapy. Nature 2004, 428, 332-337.
35. Santen, R. J.; Song, R. X.; Zhang, Z.; Kumar, R.; Jeng, M. H.; Masamura, A.; Lawrence, J., Jr.; Berstein, L.; Yue, W. Long-term estradiol deprivation in breast cancer cells up-regulates growth factor signaling and enhances estrogen sensitivity. Endocr. Relat. Cancer 2005, 12 (Suppl. 1), S61-S73. (Pubitemid 41395414)
36. Johnston, S. R. Combinations of endocrine and biological agents: present status of therapeutic and presurgical investigations. Clin. Cancer Res. 2005, 11, 889s-899s.
37. Vaziri, H.; Dessain, S. K.; Ng Eaton, E.; Imai, S. L; Frye, R. A.; Pandita, T. K.; Guarente, L.; Weinberg, R. A. hSIR2 (SIRTl) functions as an NAD-dependent p53 deacetylase. Cell 2001, 107, 149-159. (Pubitemid 33035942)
38. Anekonda, T. S.; Reddy, P. H. Neuronal protection by sirtuins in Alzheimer's disease. J. Neurochem. 2006, 96, 305-313.
39. Rodgers, J. T.; Lerin, C.; Haas, W.; Gygi, S. P.; Spiegelman, B. M.; Puigserver, P. Nutrient control of glucose homeostasis through a complex of PGC-1α and SIRT1. Nature 2005, 434, 113-118. (Pubitemid 40349395)
40. Picard, F.; Kurtev, M.; Chung, N.; Topark-Ngarm, A.; Senawong, T.; Machado De Oliveira, R.; Leid, M.; McBurney, M. W.; Guarente, L. Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR-γ. Nature 2004, 429, 111-116.
41. Bordone, L.; Motta, M. C.; Picard, F.; Robinson, A.; Jhala, U. S.; Apfeld, J.; McDonagh, T.; Lemieux, M.; McBurney, M.; Szilvasi, A.; Easlon, E. J.; Lin, S. J.; Guarente, L. Sirt1 regulates insulin secretion by repressing UCP2 in pancreatic cells. PLoS Biol. 2006, 4, e31.
42. Fu, M.; Liu, M.; Sauve, A. A.; Jiao, X.; Zhang, X.; Wu, X.; Powell, M. J.; Yang, T.; Gu, W.; Avantaggiati, M. L.; Pattabiraman, N.; Pestell, T. G.; Wang, F.; Quong, A. A.; Wang, C.; Pestell, R. G. Hormonal control of androgen receptor function through SIRTl. Mol. Cell. Biol. 2006, 26, 8122-8135.
43. Ashburner, B. P.; Westerheide, S. D.; Baldwin, A. S., Jr. The p65 (RelA) subunit of NF-KB interacts with the histone deacetylase (HDAC) corepressors HDACl and HDAC2 to negatively regulate gene expression. Mol. Cell. Biol. 2001, 21, 7065-7077.
44. Chen, L. F.; Mu, Y.; Greene, W. C. Acetylation of RelA at discrete sites regulates distinct nuclear functions of NF-KB. EMBO J. 2002, 21, 6539-6548.
45. Zhong, H.; May, M. J.; Jimi, E.; Ghosh, S. The phosphorylation status of nuclear NF-KB determines its association with CBP/p300 or HDAC-1. Mol. Cell 2009, 9, 625-636.
46. Yeung, F.; Hoberg, J. E.; Ramsey, C. S.; Keller, M. D.; Jones, D. R.; Frye, R. A.; Mayo, M. W. Modulation of NF-kB-dependent transcription and cell survival by the SIRTl deacetylase. EMBO J. 2004, 23, 2369-2380.
47. Moore, P. Connecting LKBl and AMPK links metabolism with cancer. J. Biol. 2003, 2, 24.